Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions
NCT00618163
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammation
Interventions
DRUG:
Meloxicam
Sponsor
Roxane Laboratories